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To evaluate the role of blood pressure (BP) as mediator of the effect of conscious sedation (CS)
compared to local anesthesia (LA) on functional outcome after endovascular treatment (EVT).
Methods
Patients treated in the Multicenter Randomized Clinical Trial of Endovascular Treatment for
Acute Ischemic Stroke in the Netherlands (MR CLEAN) Registry centers with CS or LA as
preferred anesthetic approach during EVT for ischemic stroke were analyzed. First, we eval-
uated the effect of CS on area under the threshold (AUT), relative difference between baseline
and lowest procedural mean arterial pressure (ΔLMAP), and procedural BP trend, compared to
LA. Second, we assessed the association between BP and functional outcome (modified Rankin
Scale [mRS]) with multivariable regression. Lastly, we evaluated whether BP explained the
effect of CS on mRS.
Results
In 440 patients with available BP data, patients treated under CS (n = 262) had larger AUTs
(median 228 vs 23 mmHg*min), larger ΔLMAP (median 16% vs 6%), and a more negative BP
trend (−0.22 vs −0.08 mm Hg/min) compared to LA (n = 178). Larger ΔLMAP and AUTs
were associated with worse mRS (adjusted common odds ratio [acOR] per 10% drop 0.87, 95%
confidence interval [CI] 0.78–0.97, and acOR per 300 mm Hg*min 0.89, 95% CI 0.82–0.97).
Patients treated under CS had worse mRS compared to LA (acOR 0.59, 95%CI 0.40–0.87) and
this association remained when adjusting for ΔLMAP and AUT (acOR 0.62, 95% CI
0.42–0.92).
Conclusions
Large BP drops are associated with worse functional outcome. However, BP drops do not
explain the worse outcomes in the CS group.
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Post hoc analyses of the Multicenter Randomized Clinical
Trial of Endovascular Treatment for Acute Ischemic Stroke in
the Netherlands (MR CLEAN) and the Highly Effective
Reperfusion evaluated in Multiple Endovascular Stroke trials
(HERMES) collaboration showed that general anesthesia
(GA) is associated with worse clinical outcomes than non-
GA. In these studies, non-GA was the composite of conscious
sedation (CS) and local anesthesia (LA) at the groin puncture
site only.1,2 Furthermore, among patients managed without
GA, CS seemed to be associated with worse functional out-
come compared to LA.3,4
Previous studies in patients receiving GA during endovascular
treatment (EVT) reported worse outcomes in patients who
experienced blood pressure (BP) drops during the procedure.5–9
The administration of anesthetic and analgesic agents may cause
gradual or sudden declines in BP. This potentially impairs
penumbra perfusion before recanalization.10–12 Considering that
hypotension leads to worse outcomes in GA, hypotensionmight
also contribute to worse outcomes in patients treated under CS
or LA. There are limited data on BP measures during EVT
among patients treated under CS or LA.13,14
In the present study, we explored the effect of CS on procedural
BP and functional outcome, using patients under LA as control.
In addition, we evaluated whether BP drops explain differences
in functional outcome between anesthetic regimens.
Methods
Study Population
We used data from the MR CLEAN Registry, which is a
prospective, multicenter, observational study including all
patients who underwent EVT for ischemic stroke due to a
large vessel occlusion in the Netherlands from March 2014
until November 2017. Detailed information on the de-
scription of variables and the methods of the MR CLEAN
Registry have been reported previously.15 First, centers were
excluded if they were non–MR CLEAN trial centers, did not
perform EVT under CS or LA as the preferred anesthetic
approach, or did not record periprocedural BP as part of
protocol care. Second, patients were excluded when they were
younger than 18 years, had an occlusion in the posterior cir-
culation, or were treated after 6.5 hours of stroke onset. Third,
we excluded patients who had no available BP data or were
treated under GA as the initial anesthetic strategy during EVT
in one of the centers with CS or LA as the preferred anesthetic
approach.
To address the risk of bias through selective hemodynamic
monitoring and BP data storage in patients at higher risk for
hemodynamic instability, we additionally evaluated baseline
characteristics of patients treated under CS and LA with and
without BP data. Procedural BP values and administered
medication were collected retrospectively from patients’ re-
cords. Study results are reported in accordance with the
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement.16
Standard Protocol Approvals, Registrations,
and Patient Consents
TheMRCLEANRegistry was approved by the medical ethics
committee of the Erasmus University MC, Rotterdam, the
Netherlands (MEC-2014-235). The institutional review
board of each participating center approved the research
protocol. At UMC Utrecht, additional approval to participate
in the study was obtained from the local research board and
ethics committee. The necessity of written informed consent
was waived.
Anesthetic Management
To limit the risk of confounding by indication, only patients
treated in centers that perform EVT under either CS or LA as
the preferred anesthetic approach were selected. CS was de-
fined as the administration of any sedative with or without
analgesics (e.g., propofol, remifentanil) from 10 minutes be-
fore groin puncture until the time of recanalization, not re-
quiring intubation. LA was defined as the use of LA (e.g.,
lidocaine) at the puncture site, without the use of any systemic
analgesics or sedatives. Patients converted to GA during the
procedure, defined as endotracheal intubation, were analyzed
according to the initial anesthetic strategy to limit con-
founding by indication. The choice of anesthetic agents was at
the discretion of the attending anesthesiologist or trained
nurse. Anesthetic reports of all patients were reviewed for
type, dosages, and time of administered anesthetic and vaso-
active agents.
Hemodynamic Management
Standard hemodynamic monitoring included oxygen satura-
tion, heart rate, noninvasive BP, and temperature. Invasive BP
monitoring was performed on an individual basis as de-
termined by the anesthesiologist. The frequency of BP
Glossary
aβ = adjusted β; acOR = adjusted common odds ratio; ASPECTS = Alberta Stroke Program Early CT Score; AUT = area under
the threshold; BP = blood pressure; CI = confidence interval; CS = conscious sedation; eTICI = extended thrombolysis in
cerebral infarction; EVT = endovascular treatment; GA = general anesthesia; IQR = interquartile range; LA = local anesthesia;
LMAP = lowest procedural mean arterial pressure; MAP = mean arterial pressure; MR CLEAN = Multicenter Randomized
Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands; mRS = modified Rankin Scale;
NIHSS = NIH Stroke Scale; RCT = randomized controlled trial; sICH = symptomatic intracranial hemorrhage.
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measurements depends on the local monitoring protocol.
Systolic BP, diastolic BP, and mean arterial pressure (MAP)
values, recorded between 10 minutes before groin puncture
and time of recanalization, were retrieved from the patients’
procedural anesthesia reports. Because there is no consensus
on which BP-derived measures are most relevant and what
should be avoided (e.g., drops, variability), we focused on 3
predefined orthogonal definitions that capture different ele-
ments of BP drops and variability17: area under the threshold
(AUT, with MAP on admission as the threshold determined
per patient) in mm Hg*minute, reflecting both the depth and
duration of the relative hypotensive episode; the relative dif-
ference between the MAP on admission and the lowest MAP
during the EVT procedure, expressed as percentage drop in
MAP (ΔLMAP), to account for shorter, larger BP drops; and
the BP trend during the procedure, defined as the slope for
each patient derived from a multilevel linear regression model
with “time since start procedure” as a predictor, with a random
Figure 1 Schematic Illustration of Procedural Blood Pressure Measures
1. Mean arterial pressure (MAP) value on admis-
sion. 2. Lowest MAP. 3. Area under the threshold.
4. Relative difference between baseline MAP and
lowest MAP (ΔLMAP). 5. Average trend (slope). ED
= emergency department; EVT = endovascular
treatment.
Figure 2 Flowchart of Patient Selection
CS = conscious sedation; EVT = endovascular treatment;
GA = general anesthesia; LA = local anesthesia; MR CLEAN =
Multicenter Randomized Clinical Trial of Endovascular
Treatment for Acute Ischemic Stroke in the Netherlands.
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slope to estimate patient-specific trends in BP measurements,
for the continuous outcome systolic BP including a random
effect for patient to account for within-patient variability
(figure 1).7,8,18–20 Hemodynamic intervention was defined as
the administration of any inotropes or vasopressors (e.g.,
ephedrine, phenylephrine) to increase BP or the use of
sympathicolytics (e.g., labetalol, clonidine) to lower BP. BP
was regulated according to institutional practices; in general,
systolic BP was maintained between 140 and 185mmHgwith
a diastolic BP below 105 mm Hg based on anesthetic critical
care recommendations.21
Outcome Measures
The primary outcome measure was score on the modified
Rankin Scale (mRS). This is a 7-point scale ranging from
0 “no symptoms” to 6 “death,” assessed at 90 days after
EVT.22 Secondary outcomes included functional in-
dependence (mRS ≤2), mortality within 90 days post EVT,
and NIH Stroke Scale (NIHSS) score indicating neurologic
deficit at 24–48 hours after EVT.23 Procedure-related out-
comes included occurrence of hemodynamic intervention,
reperfusion grade, duration of the EVT procedure, and oc-
currence of procedure-related complications (i.e., vessel per-
foration, vessel dissection, new thrombus, distal thrombus,
hemorrhage, and vasospasm). The reperfusion grade was
assessed by the extended thrombolysis in cerebral infarction
(eTICI) score on digital subtraction angiography, which
ranges from 0 “no reperfusion or anterograde flow beyond site
of occlusion” to 3 “complete reperfusion.”24 Serious adverse
events included symptomatic intracranial hemorrhage (sICH,
neurologic deterioration of ≥4 points on the NIHSS, and a
compatible hemorrhage on imaging assessed by an in-
dependent core laboratory according to the Heidelberg cri-
teria),25 extracranial hemorrhage, neurologic deterioration
(increase of ≥4 points on the NIHSS), new ischemic stroke
(imaging of new brain tissue infarction with any degree of
corresponding neurologic deficit), and pneumonia.




(n = 178) Missing
Patient characteristics
Age, y 68 (15) 69 (15)
Male sex 128 (49) 103 (58)
NIHSS 16 (11–19) 15 (11–19)
Left hemisphere 118 (45) 97 (55)
Systolic BP 149 (25) 148 (24)
Diastolic BP 84 (16) 81 (15)
IVT 203 (77) 135 (76)
Center
1: Preferred approach CSa 134 (70) 58 (30)
2: Preferred approach LA 2 (13) 13 (87)
3: Preferred approach LA 16 (57) 12 (43)
4: Preferred approach CS 110 (55) 95 (45)
Medical history
Previous stroke 44 (17) 12 (6.7) 1/0
Atrial fibrillation 58 (22) 40 (22) 4/0
Hypertension 124 (49) 94 (53) 8/5
Diabetes 42 (16) 28 (16) 3/1
Myocardial infarction 29 (11) 24 (14) 6/1
Prestroke mRS 6/2
0 182 (72) 133 (76)
1 35 (14) 18 (10)
2 29 (11) 7 (4.0)
>2 10 (3.9) 18 (10)
Imaging
Occluded segment 7/9
M1 157 (62) 108 (64)
M2 27 (11) 26 (16)
ICA 16 (6.3) 5 (3.0)
ICA-T 55 (22) 30 (18)
ASPECTS 9 (8–10) 9 (8–10) 6/9
Collaterals 9/14
Absent 14 (5.5) 9 (5.5)
Filling <50% of
occluded area
97 (38) 63 (38)
≥50% but <100% 99 (39) 65 (40)
100% of occluded
area
43 (17) 27 (16)




(n = 178) Missing
Workflow, min
Time from admission ED to
groin puncture
41 (28–69) 44 (30–73) 12/7






Abbreviations: ASPECTS = Alberta Stroke Program Early Computed To-
mography Score; BP = blood pressure; CS = conscious sedation; ED =
emergency department; ICA = internal carotid artery; ICA-T = internal carotid
artery terminus; IVT = IV thrombolysis; LA = local anesthesia; M (segment) =
middle cerebral artery; mRS = modified Rankin Scale; NIHSS = NIH Stroke
Scale.
Values are n (%); continuous data are presented as mean (SD) for normal
distributed data or as median (interquartile range) for skewed data.
a Preferred approach changed in 2017 to LA.
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Procedure-related complications and eTICI scores were
assessed by an independent core laboratory. Investigators
who assessed primary and secondary outcomes were not
aware of the type of anesthetic management during EVT.
Statistical Methods
Baseline characteristics of patients who underwent EVT under
CS were compared with patients who received LA during the
EVT procedure. Missing data were imputed using multiple im-
putations by chained equations based on relevant covariates.26
We tested 3 associations according to a 4-step approach. (1)
We evaluated the effect of anesthetic modality on the pre-
defined BP measures (i.e., AUT, ΔLMAP, and trend) and
hemodynamic interventions during EVT with multivariable
linear regression. We adjusted for age, sex, hypertension, di-
abetes, atrial fibrillation, history of myocardial infarction,
previous stroke, systolic BP on admission, baseline NIHSS,
prestroke mRS score, and treatment center. (2) We assessed
the association between the predefined BP measures and
functional outcome. This association was evaluated for all BP
measures separately with ordinal logistic regression adjusted
for age, sex, previous stroke, diabetes, atrial fibrillation, hy-
pertension, history of myocardial infarction, prestroke mRS,
baseline NIHSS, treatment with IV thrombolysis, Alberta
Stroke Program Early CT Score (ASPECTS) at baseline,
collateral score, time from stroke onset to recanalization, and
treatment center. (3) We evaluated the effect of anesthetic
modality on functional outcome using an ordinal logistic re-
gression analysis. We adjusted for the following prognostic
factors to account for potential imbalances between both
anesthetic modalities: age, sex, previous stroke, diabetes, atrial
fibrillation, hypertension, history of myocardial infarction,
prestroke mRS score, baseline NIHSS, treatment with IV
thrombolysis, ASPECTS at baseline, collateral score, time
from stroke onset to recanalization, and treatment center. (4)
To evaluate whether procedural BP explained the association
between anesthetic modality and functional outcome, we
additionally adjusted for the predefined BP measures that
were associated with functional outcome based on multivar-
iable analyses. We repeated step III for secondary outcomes
(i.e., functional independence, mortality, early NIHSS, suc-
cessful reperfusion, duration of procedure, serious adverse
events, and procedure-related complications) using the ap-
propriate regression analysis. Step IV was repeated for the
secondary outcomes: functional independence, mortality,
early NIHSS, and successful reperfusion.
To assess the association between predefined continuous BP
measures and outcome, we compared a model containing
restricted cubic splines for BP with a model including a linear
BP term, based on the log likelihood ratio. Odds ratios for the
association between BP and outcome were reported per
300 mm Hg*minutes for AUT or per 10% drop for DLMAP.7
The association between anesthetic approach and functional
outcome could possibly be confounded by conversion from
LA to CS later on during the EVT procedure as patients who
did worse during the procedure received CS later on, and
therefore were likely to have worse functional outcome. For
that reason, we performed a sensitivity analysis to compare
patients receiving CS from the start (<15 minutes from start
EVT) to patients who received LA from the beginning (this
group is a composite of LA only and CS administration later
on during the procedure, >15 minutes from EVT start). No
correction for multiple testing was performed. Statistical
analyses were performed with R 3.5.0 software (R Foundation
for Statistical Computing, Vienna, Austria).
Data Availability
Data cannot be made available, as no patient approval has
been obtained for sharing coded data. However, R syntax and
output files of the analyses will be made available on request.
Results
From the 17 participating centers in the MR CLEAN Regis-
try, only 4 centers collected BP data systematically according
to protocol and reported LA or CS as the preferred anesthetic
approach at start of the EVT (figure 2).
Study Population
Of the 969 eligible patients treated in 1 of the 4 centers with
consistent periprocedural anesthetic management, we in-
cluded 440 patients with available BP data, who underwent
EVT for acute ischemic stroke due to large vessel occlusion, of
whom 262/440 (60%) received CS and 178/440 (40%) re-
ceived LA as procedural anesthetic strategy. Patients treated
under CS were less often functionally dependent at pre-
sentation (prestroke mRS >2; 10/256, 3.8% vs 18/176, 10%)
but had a history of previous stroke (44/261 [17%] vs 12/178
[6.7%]) more often. Mean diastolic BP on admission was
lower for patients receiving LA (81 [SD 15] vs 84 [SD
16] mm Hg; table 1). We did not find substantial differences
in baseline characteristics between patients treated under LA
with available BP data (n = 178) and without BP data (n =
326). Also, no differences between patients treated under CS
with available BP data (n = 262) compared to patients treated
under CS without BP data (n = 38) were found.
Procedural Management
Average procedural systolic, diastolic, and mean arterial BPs
were lower for patients who were treated under CS (figure 3
and table 2). AUT and ΔLMAP were larger in the CS group
(median AUT 228 mm Hg*min [interquartile range (IQR)
16–790] vs 23 mm Hg*min [0–200] and median ΔLMAP
16% [5–31] vs 6% [0–16]). Procedural systolic BP trend was
more negative in patients treated under CS compared to LA
(−0.22 mm Hg [SD 0.39] vs −0.08 mm Hg [SD 0.27]). BP
elevating medications were administered more often in the
CS group than the LA group (59/262 [23%] vs 6/178
[3.4%]). BP-lowering medication was administered in 15/262
(5.7%) patients in the CS group and in 7/178 (3.9%) patients
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in the LA group. Analgesics were used in 223/262 (85%)
patients in the CS group, of which remifentanil was admin-
istered most often (116/262 [44%]). Sedatives were admin-
istered in 142/262 (54%) patients, of which propofol was
used most frequently (127/262 [48%]) (table 2). Conversion
to GA requiring intubation occurred in 3 patients in the CS
group and in 3 patients in the LA group.
Association Between Anesthetic Management
and Procedural BP
CS was associated with larger AUTs (adjusted β [aβ] 368
[95% confidence interval (CI) 242 to 494]) and larger
ΔLMAP (aβ 8.1 [95% CI 4.9 to 11.4]) compared to LA based
on multivariable linear regression. Furthermore, CS was as-
sociated with a more decreasing procedural systolic BP trend
(aβ −0.14 [95% CI −0.21 to −0.07]).
Association Between Procedural BP
and Outcome
Both ΔLMAP (adjusted common odds ratio [acOR] 0.89 per
10% drop from baseline [95% CI 0.80–0.99]) and AUT
(acOR 0.89 per 300 mm Hg*min [95% CI 0.82–0.96]) were
associated with a shift towards worse functional outcome in
multivariable analysis. Procedural BP trend was not associated
with functional outcome (acOR 0.85 per mm Hg per minute
[95% CI 0.51–1.43]).
Association Between Anesthetic Management
and Outcome
Patients undergoing EVT for acute ischemic stroke under CS
were more likely to have poor mRS scores at 90 days com-
pared to LA (acOR 0.59 [95% CI 0.40–0.87]; table 3 and
figure 4). The sensitivity analysis, comparing patients re-
ceiving CS from the beginning of the procedure (n = 51) to
patients receiving LA from the beginning of the procedure (n
= 389) (acOR 0.49 [95% CI 0.26–0.91]), obtained similar
results to the primary analysis comparing CS administration at
any time point during the procedure to LA. Functional in-
dependence at 90 days was less often seen in patients who
underwent CS compared to LA (aOR 0.49 [95% CI
0.30–0.83]). There were no differences in all-cause mortality
(aOR 1.78 [95%CI 0.96–3.02]), NIHSS at 24–48 hours post-
EVT (aβ 1.13 [95% CI −0.38 to 2.64]), and successful
reperfusion grades (aOR 1.01 [95% CI 0.66–1.65]) between
groups. Procedure duration was almost 20 minutes longer in
Figure 3 Procedural Blood Pressure (BP) for Patients Treated Under Conscious Sedation or Local Anesthesia
(A) Nonsmoothed mean systolic BP curves for
both anesthetic modalities with 95% tolerance
interval (band). (B) Smoothed mean systolic BP
curves during EVT procedure for both anesthetic
modalities (continuous line) with 95% tolerance
interval (dotted line).
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the CS group compared to the LA group (median 70 [44–90]
vs 51 [33–74] minutes). The occurrence of procedure-related
complications did not differ between patients treated under
CS and LA (9/262 [3%] vs 5/178 [4%]; aOR 1.45 [95% CI
0.89–2.31]).
Effect of BP on the Association Between
Anesthetic Management and Outcome
Additional adjustment for ΔLMAP and AUT did not explain
the association between anesthetic modality and functional
outcome (acOR 0.62 [95% CI 0.42–0.92]; table 3). ΔLMAP
and AUT did not explain the association between anesthetic
modality and any of the secondary outcomes.
Discussion
In this study, we evaluated the effect of CS on procedural hy-
potension, BP trend, and hemodynamic interventions compared
to LA. Second, we assessed whether there was an association
between the 3 predefined BPmeasures and outcomes. Third, we
evaluated the effect of CS on functional outcome compared to
LA. Finally, we explored whether the effect of anesthetic man-
agement on outcomes could be explained by procedural hypo-
tension or BP trend.We found that CSwas associated withmore
BP drops and that these BP drops were related to worse out-
comes. However, the BP drops did not explain the effect of CS
on functional outcome compared to LA.
Similar to previous studies, we found that patients treated
under CS had lower average procedural BP and more BP
drops compared to patients treated under LA. Consequently,
more hemodynamic interventions were required to increase
BP in patients treated under CS.7,13,27
A drop in MAP from baseline and larger AUT were in-
dependently associated with worse functional outcome. Simi-
lar, previous studies reported worse functional outcomes in
patients with a drop in MAP from baseline of ≥10% who re-
ceived CS or GA during the procedure.14,19,28 A recent study
found that larger AUTs were associated with worse functional
outcome in patients receiving GA as well as in patients re-
ceiving monitored anesthesia care, which is a composite of CS
and LA.7 In our study, BP drops were relatively mild, especially
in the LA group, compared to what has been observed in
patients treated under GA (median AUT in our LA group of
23 mm Hg*min [0–200] vs 984 mm Hg*min [227–1,968] in
patients treated under GA and median ΔLMAP in our LA
group of 6% [0–16] vs 39% [23–49] in patients treated under
GA).7,8,28 The small hemodynamic variability observed in pa-
tients treated under LA underlines the importance of including
LA as a treatment armbesides CS andGA in future randomized
controlled trials (RCTs) focusing on optimal anesthetic and
hemodynamic management during EVT.
In this study, patients treated under CS had worse functional out-
come compared to patients treated under LA. Hypotension and
Table 2 Procedural Anesthetic and Hemodynamic Data
CS (n = 262) LA (n = 178)
Medicationa
Muscle relaxant
Rocuronium 3 (1.1) 2 (1.1)
Inotropes/vasopressors 59 (23) 6 (3.4)
Atropine 17 (6.5) 1 (0.6)
Ephedrine 16 (6.1) 3 (1.7)
Epinephrine 2 (0.8) 0
Isoprenaline 2 (0.8) 0
Norepinephrine 20 (7.6) 3 (1.7)
Phenylephrine 24 (9.2) 2 (1.1)
Sympatholytics 15 (5.7) 7 (3.9)
Clonidine 1 (0.4) 4 (2.2)
Ketanserine 0 1 (0.6)
Labetalol 8 (3.1) 2 (1.1)
Nimodipine 6 (2.3) 0
Urapidil 0 1 (0.6)
Analgesics 223 (84) —
Alfentanil 49 (19) —
Fentanyl 11 (4.2) —
Morphine 1 (0.4) —
Remifentanil 116 (44) —
Sufentanil 46 (18) —
Sedatives 142 (53)
Esketamine 12 (4.6) —
Midazolam 8 (3.1) —
Propofol 127 (48) —
Blood pressure values, mm Hg
SBP 141 (123–164) 155 (135–173)
DBP 76 (67–84) 80 (70–92)
MAP 100 (89–115) 107 (94–121)
ΔLMAPb 16 (5.2–31) 6.0 (0–16)
AUT, mm Hg*min 228 (16–790) 23 (0–200)
Trend SBPc −0.22 (0.39) −0.08 (0.27)
Abbreviations: AUT = area under threshold; CS = conscious sedation; DBP =
diastolic blood pressure; LA = local anesthesia; DLMAP = relative difference,
baseline mean arterial pressure and lowest procedural mean arterial
pressure; MAP = mean arterial pressure; SBP = systolic blood pressure.
Values are n (%), mean (SD), or median (interquartile range).
a Percentages may add up to more than 100 owing to combined adminis-
tration of medication.
b Percentage drop from baseline MAP.
c β coefficient.
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procedural BP trend did not explain the negative association of CS
with functional outcome in our study. Because there were no large
differences in baseline characteristics between patients treated un-
der CS and LA, including neurologic deficit according to the
NIHSS at baseline, adjustments for potential covariates did not
reduce the effect of CS on outcome compared to LA. Therefore,
the effect of CS on functional outcome might be caused by con-
founders not accounted for in the analyses. The decision to perform
EVT under CS is likely to be made by the treating interventionalist
and anesthesiologist based on clinical measures not reflected by the
NIHSS score, for example patient agitation and motion. Further-
more, theNIHSSperformed in an acute and time-restrained clinical
situations might less well comprise mild to moderate neglect,
disorientation, and aphasia, which could be the determinants of the
anesthetic approach. Previous trials reported equivalent functional
outcome among patients treated under GA or CS, which is likely
due to the strict hemodynamic regimens as part of the anesthetic
protocols.29–31 A pooled analysis of these RCTs suggested that
worse outcome after EVT might be associated with BP variability
instead of the anesthetic strategy itself. However, conclusions of this
study were restricted to the association between BP variability and
neurologic outcomes, stratified by anesthetic modality.28
In several EVT-capable centers with CS or LA as the preferred
anesthetic approach during EVT, the involvement of the an-
esthesiologist is limited to patients who are hemodynamically
Table 3 Effect of Conscious Sedation (CS) vs Local Anesthesia (LA) on Outcomes, Unadjusted (model A), Adjusted for
Potential Confounding Variables (model B), and With Additional Adjustment for Blood Pressure (model C)
CS (n = 262) LA (n = 178)
A: Unadjusted effect,
CS vs LA, (c)OR (95% CI)
B: Adjusted effect, CS vs
LA, a(c)OR (95% CI)
C: Adjusted effect, including
ΔLMAPa and AUT,b CS vs LA,
a(c)OR (95% CI)
Primary outcome
mRS at 90 days 4 (2–6) 3 (1–4) 0.56 (0.40–0.79) 0.59 (0.40–0.87) 0.62 (0.42–0.92)
Secondary outcomes,
clinical
mRS ≤2 at 90 days 80 (34) 82 (50) 0.53 (0.36–0.78) 0.49 (0.30–0.83) 0.53 (0.30–0.85)
Mortality at 90 days 70 (29) 33 (20) 1.51 (0.95–2.37) 1.78 (0.96–3.02) 1.70 (0.95–3.18)






175 (69) 122 (70) 0.96 (0.64–1.46) 1.01 (0.66–1.65) 1.11 (0.70–1.81)
Secondary outcomes,
workflow





9 (4) 5 (3) 1.57 (1.01–2.45) 1.45 (0.89–2.31)
Symptomatic ICH 13 (5.0) 4 (2.3) 2.27 (0.79–8.17) 2.74 (0.87–10.4)
ECH 5 (1.9) 7 (3.9) 0.48 (0.14–1.51) 0.52 (0.13–1.98)
Neurologic
deterioration
18 (6.9) 8 (4.5) 1.57 (0.69–3.90) 1.49 (0.57–4.14)
New ischemic stroke 7 (2.7) 2 (1.1) 2.42 (0.58–16.3) 4.80 (0.84–20.1)
Pneumonia 28 (11) 16 (9.0) 1.21 (0.64–2.36) 1.04 (0.50–2.23)
Abbreviations: acOR = adjusted common odds ratio; AUT = area under threshold; CI = confidence interval; ECH = extracranial hemorrhage; eTICI = extended
thrombolysis in cerebral infarction; ICH = intracranial hemorrhage; ΔLMAP = relative difference, baselinemean arterial pressure and lowest proceduralmean
arterial pressure; mRS = modified Rankin Scale; NIHSS = NIH Stroke Scale.
Values are n (%) or median (interquartile range). A: Univariable regression analyses; B: multivariable regression analyses (adjusted for age, sex, baseline
NIHSS, prestroke mRS, history of stroke, hypertension, diabetes, atrial fibrillation, myocardial infarction, IV thrombolysis, Alberta Stroke Program Early CT
Score score at baseline, time between stroke onset and recanalization, center); C:multivariable regression analyses (adjusted for the same variables as in step
2 with an additional adjustment for DLMAP and AUT to evaluate whether hypotension explains the effect of CS on outcome, i.e., reduces the effect estimate).
a Per 10% drop.
b Per 300 mm Hg*minute.
c Reported effect measure is β coefficient.
d Adjustment for time between stroke onset and groin puncture instead of time between stroke onset and recanalization.
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unstable or require GA. Because these results suggest that BP
drops and hemodynamic interventions are seen during both
CS and LA, hemodynamic monitoring and rapid treatment of
hemodynamic instability during EVT should not be restricted
to patients treated under GA only.
Our study has several limitations. First, due to the retro-
spective observational design of this study, results could have
been confounded by variables not adjusted for in the analyses.
Patients who are more affected at presentation are more likely
to receive CS and hemodynamic monitoring, meaning re-
sidual confounding is present in this cohort. To limit the risk
of confounding by indication, we performed a sensitivity
analysis for patients who received sedatives or analgesics from
the beginning of the procedure. In the sensitivity analysis
among patients who received CS from the beginning of the
EVT procedure compared to patients receiving LA from the
beginning, a similar effect of CS on outcome was found. This
suggests that conversion from LA to CS was not directly
related to patient status at baseline and confounding by in-
dication might be less likely. Furthermore, although we se-
lected centers reporting either CS or LA as the preferred
approach, we observed that a significant number of patients
received the nonpreferred initial anesthetic approach. Because
we selected centers with CS or LA as the preferred anesthetic
approach and standard hemodynamic monitoring, the gen-
eralizability of our findings to patients treated under different
anesthetic or hemodynamic regimens is limited. Second, there
is no consensus on how to quantify procedural hypotension
and BP variability. A different quantification of procedural
hemodynamics could alter the effect of anesthetics on out-
come. Lastly, as heterogeneity in anesthetic approach defini-
tions exists, comparability is difficult as sedation is a
continuum ranging from minimal to deep sedation, with a
concomitant variety in physiologic effects (e.g., arterial hy-
potension, bradycardia, respiratory depression).
Hemodynamic interventions to maintain hemodynamic sta-
bility are common during EVT under CS and LA. In a cohort
of patients treated with EVT under strict BP management,
decreases in BP are small and do not explain the differences in
functional outcome between patients treated under CS and
LA. As BP drops by means of ΔLMAP and AUT are in-
dependently associated with worse functional outcome, we
advocate to monitor and avoid BP drops (i.e., ensure hemo-
dynamic stability) during EVT. Further randomized con-
trolled trials are needed to determine whether hemodynamic
interventions improve patient outcomes.
Study Funding
The authors received no funding for this study. The MR
CLEAN Registry is partially funded by unrestricted grants
from Toegepast Wetenschappelijk Instituut voor Neuro-
modulatie, Twente University (TWIN), Erasmus MC Uni-
versity Medical Center, Maastricht University Medical
Center, and Amsterdam University Medical Center. The
study was additionally funded by the European Union’s Ho-
rizon 2020 research and innovation program under grant
agreement 777072 (In Silico Trials for Treatment of Acute
Ischemic Stroke [INSIST]), which played no role in study
design, patient enrollment, data collection, analysis, or writing
of the manuscript. Erasmus MC received compensation from
Stryker, Medtronic, and Bracco Imaging Ltd for activities of
A.v.d.L. and D.W.J.D as a consultant. Amsterdam University
Medical Center received funds from Stryker for consultations
by C.B.L.M.M. Maastricht University Medical Center re-
ceived funds from Stryker and Codman for consultations by
W.H.v.Z.
Disclosure
A. van der Lugt and D.W.J. Dippel are the recipients of un-
restricted grants from Dutch Heart Foundation, Dutch Brain
Foundation, The Netherlands Organisation for Health Re-
search and Development, Health Holland Top Sector Life
Science, AngioCare BV, Covidien/EV3, MEDAC GmbH/
LAMEPRO, TopMedical/Concentric, Thrombolytic Science
LLC, Stryker, Medtronic and Penumbra Inc. for the conduct
of trials of acute treatment for stroke. C.B.L.M. Majoie
Figure 4 Primary Outcome on the Modified Rankin Scale (mRS) by Preferred Anesthetic Method
Neurology.org/N Neurology | Volume 96, Number 2 | January 12, 2021 e179
received funds from TWIN Foundation and European
Commission (related to this project, paid to institution) and
from CVON/Dutch Heart Foundation, Stryker, Health
Evaluation Netherlands (unrelated; all paid to institution),
and is shareholder of Nico.lab, a company that focuses on the
use of artificial intelligence for medical imaging analysis. N.
Samules, R.A. van de Graaf, C.A.L. van den Berg, D. Nieboer,
I. Eralp, K.M. Treurniet, B.J. Emmer, R.V. Immink, R.P.H.
Bokkers, M. Uyttenboogaart, B.A.A.M. van Hasselt, J.
Mühling, J.F. Burke, B. Roozenbeek, H.F. Lingsma, and
A.C.G.M. van Es report no disclosures. Go to Neurology.org/
N for full disclosures.
Publication History
Received by Neurology April 10, 2020. Accepted in final form
August 24, 2020.
References
1. Berkhemer OA, van den Berg LA, Fransen PS, et al. The effect of anesthetic man-
agement during intra-arterial therapy for acute stroke in MR CLEAN. Neurology
2016;87:656–664.
2. Campbell BCV, van Zwam WH, Goyal M, et al. Effect of general anaesthesia on
functional outcome in patients with anterior circulation ischaemic stroke having
endovascular thrombectomy versus standard care: a meta-analysis of individual pa-
tient data. Lancet Neurol 2018;17:47–53.
3. van de Graaf RA, Samuels N, Mulder M, et al. Conscious sedation or local anesthesia
during endovascular treatment for acute ischemic stroke. Neurology 2018;91:e19–e25.
4. Goldhoorn RB, Bernsen MLE, Hofmeijer J, et al. Anesthetic management during
endovascular treatment of acute ischemic stroke in the MR CLEAN registry. Neu-
rology 2020;94:e97-e106.
5. Davis MJ, Menon BK, Baghirzada LB, et al. Anesthetic management and outcome in
patients during endovascular therapy for acute stroke. Anesthesiology 2012;116:
396–405.
6. Lowhagen Henden P, Rentzos A, Karlsson JE, et al. Hypotension during endovascular


















Study concept and design,
data acquisition, statistical








Major role in data
acquisition, statistical



















































































Acquisition of data, critical







Acquisition of data, critical







Critical interpretation of the








Critical revision of the
manuscript for intellectual
content





Study concept and design,








Study concept and design,
interpretation of the data,








Study concept and design,
statistical analyses,
interpretation of the data,








Study concept and design,
interpretation of the data,




Coinvestigators are listed at links.lww.com/WNL/B252
e180 Neurology | Volume 96, Number 2 | January 12, 2021 Neurology.org/N
7. Petersen NH, Ortega-Gutierrez S, Wang A, et al. Decreases in blood pressure during
thrombectomy are associated with larger infarct volumes and worse functional out-
come. Stroke 2019;50:1797–1804.
8. Treurniet KM, Berkhemer OA, Immink RV, et al. A decrease in blood pressure is
associated with unfavorable outcome in patients undergoing thrombectomy under
general anesthesia. J Neurointerv Surg 2018;10:107–111.
9. Pikija S, Trkulja V, Ramesmayer C, et al. Higher blood pressure during endovascular
thrombectomy in anterior circulation stroke is associated with better outcomes.
J Stroke 2018;20:373–384.
10. Devlin JW, Mallow-Corbett S, Riker RR. Adverse drug events associated with the use
of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med
2010;38:S231–S243.
11. Hug CC Jr, McLeskey CH, Nahrwold ML, et al. Hemodynamic effects of propofol:
data from over 25,000 patients. Anesth Analg 1993;77:S21–S29.
12. Maier B, Fahed R, Khoury N, et al. Association of blood pressure during thrombec-
tomy for acute ischemic stroke with functional outcome: a systematic review. Stroke
2019;50:2805–2812.
13. Alcaraz G, Chui J, Schaafsma J, et al. Hemodynamic management of patients during
endovascular treatment of acute ischemic stroke under conscious sedation: a retro-
spective cohort study. J Neurosurg Anesthesiol 2019;31:299–305.
14. Whalin MK, Halenda KM, Haussen DC, et al. Even small decreases in blood pressure
during conscious sedation affect clinical outcome after stroke thrombectomy: an
analysis of hemodynamic thresholds. AJNR Am J Neuroradiol 2017;38:294–298.
15. Jansen IGH, Mulder M, Goldhoorn RB; investigators MCR. Endovascular treatment
for acute ischaemic stroke in routine clinical practice: prospective, observational co-
hort study (MR CLEAN Registry). Bmj 2018;360:k949.
16. von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of obser-
vational studies in Epidemiology (STROBE) statement: guidelines for reporting
observational studies. Int J Surg 2014;12:1495–1499.
17. Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ.
Incidence of intraoperative hypotension as a function of the chosen definition: lit-
erature definitions applied to a retrospective cohort using automated data collection.
Anesthesiology 2007;107:213–220.
18. Whalin MK, Halenda KM, Haussen DC, et al. Even small decreases in blood pressure
during conscious sedation affect clinical outcome after stroke thrombectomy: an
analysis of hemodynamic thresholds. Am J Neuroradiol 2017;38:294–298.
19. Valent A, Sajadhoussen A, Maier B, et al. A 10% blood pressure drop from baseline
during mechanical thrombectomy for stroke is strongly associated with worse neu-
rological outcomes. J Neurointerv Surg 2020;12:363–369.
20. Monk TG, Bronsert MR, Henderson WG, et al. Association between intraoperative
hypotension and hypertension and 30-day postoperative mortality in noncardiac
surgery. Anesthesiology 2015;123:307–319.
21. Talke PO, Sharma D, Heyer EJ, Bergese SD, Blackham KA, Stevens RD. Society for
Neuroscience in Anesthesiology and Critical Care Expert Consensus Statement:
Anesthetic Management of Endovascular Treatment for Acute Ischemic Stroke: en-
dorsed by the Society of NeuroInterventional Surgery and the Neurocritical Care
Society. J Neurosurg Anesthesiol 2014;26:95–108.
22. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver
agreement for the assessment of handicap in stroke patients. Stroke 1988;19:
604–607.
23. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a
clinical examination scale. Stroke 1989;20:864–870.
24. Goyal M, Fargen KM, Turk AS, et al. 2C or not 2C: defining an improved re-
vascularization grading scale and the need for standardization of angiography out-
comes in stroke trials. J Neurointerv Surg 2014;6:83–86.
25. von Kummer R, Broderick JP, Campbell BC, et al. The Heidelberg bleeding classi-
fication: classification of bleeding events after ischemic stroke and reperfusion ther-
apy. Stroke 2015;46:2981–2986.
26. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle in-
troduction to imputation of missing values. J Clin Epidemiol 2006;59:1087–1091.
27. Petersen NH, Silverman A, Kimmel AC, Sheth KN. Response by Petersen et al to
letter regarding article, “Decreases in blood pressure during thrombectomy are as-
sociated with larger infarct volumes and worse functional outcome.” Stroke 2019;50:
e321-e322.
28. Rasmussen M, Schonenberger S, Henden PL, et al. Blood pressure thresholds and
neurologic outcomes after endovascular therapy for acute ischemic stroke: an analysis
of individual patient data from 3 randomized clinical trials. JAMA Neurol 2020;77:
622–631.
29. Schonenberger S, Uhlmann L, Hacke W, et al. Effect of conscious sedation vs general
anesthesia on early neurological improvement among patients with ischemic stroke
undergoing endovascular thrombectomy: a randomized clinical trial. JAMA 2016;316:
1986–1996.
30. Lowhagen Henden P, Rentzos A, Karlsson JE, et al. General anesthesia versus con-
scious sedation for endovascular treatment of acute ischemic stroke: the AnStroke
Trial (Anesthesia During Stroke). Stroke 2017;48:1601–1607.
31. Simonsen CZ, Yoo AJ, Sorensen LH, et al. Effect of general anesthesia and conscious
sedation during endovascular therapy on infarct growth and clinical outcomes in acute
ischemic stroke: a randomized clinical trial. JAMA Neurol 2018;75:470–477.
Neurology.org/N Neurology | Volume 96, Number 2 | January 12, 2021 e181
DOI 10.1212/WNL.0000000000011006
2021;96;e171-e181 Published Online before print October 7, 2020Neurology 
Noor Samuels, Rob A. van de Graaf, Carlijn A.L. van den Berg, et al. 
Anesthesia
Blood Pressure During Endovascular Treatment Under Conscious Sedation or Local




including high resolution figures, can be found at:
References
 http://n.neurology.org/content/96/2/e171.full#ref-list-1













its entirety can be found online at:




Information about ordering reprints can be found online:
ISSN: 0028-3878. Online ISSN: 1526-632X.
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.. All rights reserved. Print
1951, it is now a weekly with 48 issues per year. Copyright Copyright © 2020 The Author(s). Published by 
® is the official journal of the American Academy of Neurology. Published continuously sinceNeurology 
